EssilorLuxottica S.A., FR0000121667

EssilorLuxottica stock carries 9.7 percent H1 growth into Q3

Published on 10/06/2026 at 16:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EssilorLuxottica stock posted 9.7 percent constant-currency revenue growth in H1 2026, while adjusted operating profit rose 15 percent. UBS cut its target to EUR 247 on October 5.

Flatlay: Aktienzertifikat, ISIN-Karte und Optiker-Utensilien
EssilorLuxottica FR0000121667 Flatlay mit Aktienzertifikat ISIN-Karte Optiker-Werkzeuge Brillengläser Goldstift auf weißem Marmor, Illustration mit AI erstellt.

EssilorLuxottica stock (ISIN FR0000121667) was trading at EUR 145.60 on Euronext Paris at 4:38 p.m. CEST on October 6, 2026, up 0.76 percent from the prior close. The H1 2026 figures show why the October selloff has not erased the group's operating momentum.

H1 growth stays in double digits

In the H1 2026 earnings call published by Yahoo Finance on July 28, 2026, management reported revenue growth of 9.7 percent at constant currency and 5.7 percent at current exchange rates. Adjusted operating profit advanced 15 percent, ahead of revenue growth and pointing to operating leverage despite continued investment in research, development, artificial intelligence and medical capabilities.

The same call put H1 free cash flow at EUR 1.067 billion, more than EUR 100 million above the comparable period. The second quarter generated 8.7 percent constant-currency revenue growth and 7.2 percent growth at current exchange rates, giving the business a quantified base for the October sales update.

Analysts lower targets ahead of Q3

UBS retained its Buy rating but reduced its price target from EUR 282 to EUR 247 on October 5, 2026, according to finanzen.ch. Deutsche Bank Research kept its Hold rating and cut its target from EUR 174 to EUR 157 on the same date, as reported by wallstreetONLINE.

The consensus picture remains more constructive than the latest individual revisions. Marketscreener lists a Buy consensus from 23 analysts and an average target price of EUR 242.70, while the latest target cuts show that analysts are recalibrating expectations before the next operating update.

Q3 sales date sets the next test

EssilorLuxottica lists October 19, 2026, for its Q3 2026 sales and revenue release. The date matters because the H1 comparison combines healthy constant-currency growth with currency pressure, while analysts are also questioning the pace of smart-eyewear adoption.

For investors, the key comparison is now between the 9.7 percent H1 constant-currency growth rate and the 15 percent increase in adjusted operating profit. That spread gives the upcoming sales release a more specific test than the share price alone.

Stock trades well above its yearly low

At EUR 145.60 on October 6, 2026, the stock was within its EUR 138.30 to EUR 323.80 52-week range on Euronext Paris. EssilorLuxottica's market capitalization stood at EUR 66.9 billion and trading volume reached 255,205 shares at 4:38 p.m. CEST.

EssilorLuxottica stock facts

  • Company: EssilorLuxottica S.A.
  • ISIN: FR0000121667
  • Ticker: EL
  • Trading venue: Euronext Paris
  • Price (as of October 6, 2026, 4:38 p.m. CEST): EUR 145.60
  • Market capitalization: EUR 66.9 billion (as of October 6, 2026)
  • 52-week range: EUR 138.30-EUR 323.80 (as of October 6, 2026)
  • Sector / Industry: Medical Equipment, Supplies and Distribution
  • Index membership: CAC 40, Euro Stoxx 50

Upcoming dates for EssilorLuxottica stock

  • October 19, 2026: Q3 2026 sales and revenue release

More news and analyses on EssilorLuxottica stock

Disclaimer...

en | FR0000121667 | ESSILORLUXOTTICA S.A. | boerse | 70243419 | bgmi